X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1492) 1492
Publication (89) 89
Book Review (14) 14
Book Chapter (8) 8
Magazine Article (6) 6
Book / eBook (5) 5
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (952) 952
animals (694) 694
arsenicals - administration & dosage (666) 666
male (608) 608
index medicus (604) 604
female (495) 495
oxides - administration & dosage (456) 456
arsenic trioxide (447) 447
arsenic (438) 438
arsenicals - therapeutic use (344) 344
arsenicals - pharmacology (337) 337
oncology (331) 331
acute promyelocytic leukemia (303) 303
leukemia, promyelocytic, acute - drug therapy (289) 289
mice (285) 285
adult (271) 271
middle aged (266) 266
hematology (247) 247
oxides - therapeutic use (238) 238
apoptosis (229) 229
arsenicals - adverse effects (224) 224
toxicology (224) 224
oxides - pharmacology (210) 210
antineoplastic combined chemotherapy protocols - therapeutic use (201) 201
rats (198) 198
apoptosis - drug effects (189) 189
cancer (189) 189
antineoplastic agents - therapeutic use (185) 185
arsenicals (184) 184
aged (183) 183
antineoplastic agents - administration & dosage (181) 181
treatment outcome (177) 177
cell line, tumor (159) 159
tretinoin - administration & dosage (159) 159
pharmacology & pharmacy (157) 157
chemotherapy (154) 154
oxides - adverse effects (154) 154
toxicity (153) 153
dose-response relationship, drug (148) 148
antineoplastic agents - pharmacology (145) 145
leukemia (131) 131
trans-retinoic acid (127) 127
adolescent (119) 119
remission induction (111) 111
administration, oral (108) 108
arsenicals - pharmacokinetics (105) 105
cells (105) 105
antineoplastic agents - adverse effects (104) 104
therapy (102) 102
research (101) 101
time factors (100) 100
environmental sciences (96) 96
analysis (94) 94
in-vitro (93) 93
cell proliferation - drug effects (90) 90
arsenicals - metabolism (89) 89
recurrence (88) 88
health aspects (87) 87
drug synergism (85) 85
oxidative stress (83) 83
arsenic compounds (80) 80
oxides - toxicity (78) 78
care and treatment (75) 75
arsenicals - urine (74) 74
arsenic poisoning (73) 73
metabolism (73) 73
public, environmental & occupational health (73) 73
expression (69) 69
metabolites (68) 68
child (67) 67
methylation (66) 66
arsenic - metabolism (64) 64
article (64) 64
drinking-water (64) 64
medicine (64) 64
young adult (62) 62
activation (61) 61
cell survival - drug effects (61) 61
exposure (60) 60
leukemia, promyelocytic, acute - pathology (59) 59
speciation (59) 59
arsenic - toxicity (58) 58
liver - metabolism (58) 58
tretinoin - therapeutic use (58) 58
arsenicals - chemistry (57) 57
dimethylarsinic acid (57) 57
reactive oxygen species - metabolism (57) 57
remission (57) 57
induction (56) 56
as2o3 (55) 55
inhibition (55) 55
leukemia, promyelocytic, acute - genetics (55) 55
induced apoptosis (54) 54
tissue distribution (54) 54
retinoic acid (53) 53
glutathione (52) 52
prognosis (52) 52
urine (52) 52
antineoplastic combined chemotherapy protocols - adverse effects (51) 51
proteins (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1359) 1359
Chinese (74) 74
French (26) 26
Japanese (14) 14
Russian (13) 13
German (9) 9
Spanish (5) 5
Czech (3) 3
Ukrainian (3) 3
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1570 - 1580
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 12/2017, Volume 268, pp. 92 - 101
Myelodysplastic syndromes (MDS) are a diverse group of bone marrow disorders and clonal hematopoietic stem cell disorders characterized by abnormal blood... 
Bone marrow | Decitabine | Arsenic trioxide | Delivery | Nanoparticle | Myelodysplastic syndrome | APOPTOSIS | DNA METHYLATION | DRUG-DELIVERY | 5-AZACYTIDINE | COMBINATION | CANCER | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | RETINOIC ACID | PHARMACOLOGY & PHARMACY | POLYMER HYBRID NANOPARTICLES | ACUTE PROMYELOCYTIC LEUKEMIA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanoparticles - chemistry | Apoptosis - drug effects | Oxides - chemistry | Azacitidine - chemistry | Phosphatidylethanolamines - therapeutic use | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyethylene Glycols - therapeutic use | Alendronate - chemistry | Alendronate - therapeutic use | Tissue Distribution | Arsenicals - therapeutic use | Nanoparticles - therapeutic use | Bone and Bones - metabolism | Phosphatidylethanolamines - pharmacokinetics | Bone Marrow Cells - drug effects | Antineoplastic Agents - pharmacokinetics | Arsenicals - pharmacokinetics | Alendronate - pharmacokinetics | Myelodysplastic Syndromes - drug therapy | Oxides - administration & dosage | Azacitidine - administration & dosage | Oxides - therapeutic use | Cell Survival - drug effects | Arsenic Trioxide | Azacitidine - pharmacokinetics | Myelodysplastic Syndromes - metabolism | Cells, Cultured | Polyethylene Glycols - pharmacokinetics | Azacitidine - analogs & derivatives | Mice, Transgenic | Phosphatidylethanolamines - administration & dosage | Antineoplastic Agents - chemistry | Polyethylene Glycols - administration & dosage | Oxides - pharmacokinetics | Arsenicals - administration & dosage | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Arsenicals - chemistry | Nanoparticles - administration & dosage | Phosphatidylethanolamines - chemistry | Alendronate - administration & dosage | Azacitidine - therapeutic use | Medical research | Medical colleges | Medical examination | Arsenic | Analysis | Medicine, Experimental | Hematopoietic stem cells | Blood | Index Medicus | delivery | nanoparticle | decitabine | arsenic trioxide | bone marrow
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2009, Volume 27, Issue 4, pp. 504 - 510
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 497 - 503
Aa total of 105 patients (age ≥18 years) with newly diagnosed low or intermediate risk acute promyelocytic leukaemia ( APL ) were treated with a standard... 
malignant haematology | leukaemia trials | acute promyelocytic leukaemia | leukaemia clinical | Leukaemia trials | Malignant haematology | Leukaemia clinical | Acute promyelocytic leukaemia | SURVIVAL | MULTICENTER | PETHEMA | ADULTS | C9710 | TRANS-RETINOIC ACID | CHEMOTHERAPY | INTERGROUP | ATRA | HEMATOLOGY | REMISSION | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Risk | Consolidation Chemotherapy | Cytarabine - adverse effects | Biomarkers, Tumor | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Aminoglycosides - administration & dosage | Adult | Female | Maintenance Chemotherapy | Daunorubicin - administration & dosage | Oxides - administration & dosage | Arsenicals - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Tretinoin - administration & dosage | Mercaptopurine - administration & dosage | Mercaptopurine - adverse effects | Treatment Outcome | Oxides - adverse effects | Remission Induction | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Disease-Free Survival | Methotrexate - adverse effects | Arsenicals - administration & dosage | Animals | Platelet Count | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Dogs | Tretinoin - adverse effects | Methotrexate - administration & dosage | Aged | Oncogene Proteins, Fusion - blood | Aminoglycosides - adverse effects | Leukemia, Promyelocytic, Acute - drug therapy | Arsenic | 4. Leukaemia Clinical | 3. Leukaemia Trials | 1. Acute Promyelocytic Leukaemia | 2. Malignant Haematology
Journal Article
Blood, ISSN 0006-4971, 09/2011, Volume 118, Issue 9, pp. 2389 - 2394
Journal Article
Journal Article
Journal Article
Environmental Health Perspectives, ISSN 0091-6765, 07/2013, Volume 121, Issue 7, pp. 818 - 824
BACKGROUND: Inorganic arsenic (iAs) causes cancer and possibly other adverse health outcomes. Arsenic-based drugs are permitted in poultry production; however,... 
Antimicrobial | FDA | Roxarsone | Arsenic | Poultry | Nitarsone | Chicken | Food and Drug Administration | MORTALITY | antimicrobial | RISKS | chicken | poultry | ACID | nitarsone | arsenic | ENVIRONMENTAL SCIENCES | BIOTRANSFORMATION | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | roxarsone | POULTRY LITTER | SPECIATION | TOXICOLOGY | DRINKING-WATER | EXPOSURE | RICE | United States - epidemiology | Cooking | Coccidiostats - metabolism | Lung Neoplasms - chemically induced | Humans | Environmental Pollutants - metabolism | Urinary Bladder Neoplasms - chemically induced | Chickens - metabolism | Pectoralis Muscles - metabolism | Arsenicals - metabolism | Roxarsone - administration & dosage | Environmental Pollutants - administration & dosage | Roxarsone - metabolism | Urinary Bladder Neoplasms - epidemiology | Coccidiostats - analysis | Risk Assessment | Meat - analysis | Coccidiostats - administration & dosage | Mass Spectrometry - veterinary | Arsenicals - analysis | Environmental Exposure | Arsenicals - administration & dosage | Animals | Lung Neoplasms - epidemiology | Roxarsone - analysis | Chromatography, High Pressure Liquid - veterinary | Environmental Pollutants - analysis | Chronic diseases | Research | Health aspects | Chickens | Risk factors | Drugs | Studies | Sales | Antibiotics | Laboratories | FDA approval | Public health | Marketing | Cancer | Shipments | Index Medicus | Heating | Consumers | Meat
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. e534 - e536
Journal Article
Blood, ISSN 0006-4971, 03/2017, Volume 129, Issue 10, pp. 1275 - 1283
Journal Article